---

---

symbols : VTRS   

save search

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| 0.0% | O: -0.71% H: 0.0% C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| 0.22% | O: -1.46% H: 0.0% C: 0.0%
PHG | $20.33 -0.39% 0.0% 740K |

Health Technology

| 0.0% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M |

Health Technology

| 0.0% | O: -1.63% H: 0.0% C: 0.0%
VRNA | $16.21 2.6% 2.53% 550K |

Health Technology

| 0.0% | O: 1.27% H: 0.0% C: 0.0%
reach treatment research market

---

Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -0.09% | O: 0.88% H: 1.84% C: -0.96%
commercial

---

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -2.16% | O: -0.17% H: 0.17% C: -1.9%
RVNC | $3.82 -3.78% -3.93% 2.4M |

Health Technology

| -11.38% | O: -2.01% H: 1.37% C: -5.92%
daxxify neurology meeting

---

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K |

Health Technology

| -12.02% | O: -100.0% H: NaN% C: Infinity%
SNYNF | $92.966 -2.18% 630 |

Health Technology

| -1.37% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | $9.2715 -1.11% 500K |

Manufacturing

| -11.45% | O: -0.29% H: 0.0% C: -1.97%
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -3.41% | O: -0.6% H: 1.03% C: 0.52%
TMO | $554.55 -0.6% 0.0% 1M |

Health Technology

| -5.32% | O: -2.01% H: 0.0% C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| -1.32% | O: -1.16% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M |

Health Technology

| -1.39% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $108.92 -1.79% -1.83% 540K |

Health Technology

| -4.09% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630 |

Health Technology

| 0.3% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $135.94 -4.19% 770 |

Health Technology

| 2.04% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -4.07% | O: -0.25% H: 1.1% C: -0.17%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| -1.44% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.26 -0.52% 0.04% 12M |

Health Technology

| -5.48% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.745 1.33% 0.0% 2.5M |

Health Technology

| -17.1% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $162.54 0.54% 0.0% 4.8M |

Health Technology

| -3.72% | O: 0.77% H: 1.63% C: 0.35%
SNY | $45.81 -0.93% -0.94% 1.4M |

Health Technology

| -0.12% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M |

Health Technology

| 1.9% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-03 (Crawled : 02:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -5.19% | O: -0.42% H: 2.78% C: 1.09%
SNY | $45.81 -0.93% -0.94% 1.4M |

Health Technology

| -1.74% | O: 0.69% H: 0.0% C: 0.0%
report reach contraceptive market

---

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -4.63% | O: 0.84% H: 0.0% C: -0.25%
OCUP | $1.75 -0.57% -0.57% 110K |

Health Technology

| -12.0% | O: 1.0% H: 10.4% C: 10.4%
solution commercial ryzumvl apx3330

---

Idorsia and Viatris successfully close the transaction for the global research and development collaboration
Published: 2024-03-18 (Crawled : 06:00) - globenewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -5.19% | O: -0.59% H: 0.59% C: -0.93%
research global collaboration

---

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
Published: 2024-03-11 (Crawled : 14:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -7.67% | O: -0.82% H: 0.7% C: -1.56%
acquired

---

Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 17:00) - biospace.com/
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -10.09% | O: 0.0% H: 0.08% C: -1.83%
RVNC | $3.82 -3.78% -3.93% 2.4M |

Health Technology

| -43.12% | O: -11.6% H: 3.89% C: -1.62%
million offering

---

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
Published: 2024-02-28 (Crawled : 06:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -14.44% | O: -0.15% H: 2.57% C: -6.96%
research global collaboration

---

Idorsia and Viatris enter into a significant global research and development collaboration
Published: 2024-02-28 (Crawled : 06:00) - globenewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -14.44% | O: -0.15% H: 2.57% C: -6.96%
research global collaboration

---

Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -14.44% | O: -0.15% H: 2.57% C: -6.96%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| -8.47% | O: 0.05% H: 0.06% C: -0.95%
JNJ | $144.45 -2.13% 0.03% 13M |

Health Technology

| -7.76% | O: 0.67% H: 0.0% C: 0.0%
ABT | $109.23 0.31% 0.0% 7.2M |

Health Technology

| -7.85% | O: 1.12% H: 0.52% C: 0.47%
report india global market

---

Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -15.27% | O: 0.0% H: 1.93% C: 1.27%
NVO | $123.45 -0.36% 0.03% 3M |

Health Technology

| -0.5% | O: -0.68% H: 0.4% C: -0.18%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| -8.16% | O: 0.89% H: 0.4% C: 0.17%
JNJ | $144.45 -2.13% 0.03% 13M |

Health Technology

| -8.01% | O: 0.28% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M |

Health Technology

| -2.18% | O: 0.97% H: 0.0% C: 0.0%
report revenue global insulin growth market

---

Binge-eating Disorder Treatment Market Research Report 2024
Published: 2024-02-23 (Crawled : 02:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -15.27% | O: 0.0% H: 1.93% C: 1.27%
TNXP | $0.1493 2.33% 2.28% 5.2M |

Health Technology

| -53.89% | O: 0.0% H: 4.3% C: 1.77%
report treatment research market

---

Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -14.5% | O: -0.15% H: 0.76% C: 0.3%
RVNC | $3.82 -3.78% -3.93% 2.4M |

Health Technology

| -27.95% | O: 0.18% H: 0.72% C: -2.72%
year financial results

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $195.16 -0.83% -0.85% 870K |

Health Technology

| Email alert Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
AZN | $68.27 -0.67% -0.67% 3.8M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
GSK | $39.95 -1.36% 0.0% 2.4M |

Health Technology

| Email alert Add to watchlist
AZNCF | $135.94 -4.19% 770 |

Health Technology

| Email alert Add to watchlist
JAZZ | $108.92 -1.79% -1.83% 540K |

Health Technology

| Email alert Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies - Technavio
Published: 2024-02-08 (Crawled : 06:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
ABBV | $162.54 0.54% 0.0% 4.8M |

Health Technology

| -6.84% | O: 0.5% H: 0.0% C: 0.0%
ABT | $109.23 0.31% 0.0% 7.2M |

Health Technology

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
companies abbvie million contraceptive key market

---

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ 6 d | $0.0018 -50.0% 420K |

n/a

| 157.14% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | $92.966 -2.18% 630 |

Health Technology

| -0.76% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
NVS | $93.2 -1.28% 0.0% 1.6M |

Health Technology

| -8.75% | O: -1.57% H: 0.26% C: -0.47%
GSK | $39.95 -1.36% 0.0% 2.4M |

Health Technology

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.57 -1.17% 0.0% 2.7M |

Health Technology

| 1.68% | O: -0.96% H: 5.91% C: 3.74%
ABT | $109.23 0.31% 0.0% 7.2M |

Health Technology

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M |

Health Technology

| -0.59% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M |

Health Technology

| -10.26% | O: 0.38% H: 0.34% C: -0.72%
america growth market

---

Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
VTRS | $11.12 -1.77% -1.8% 6.8M |

Health Technology

| -3.82% | O: -0.42% H: 1.75% C: 1.28%
RVNC | $3.82 -3.78% -3.93% 2.4M |

Health Technology

| -21.07% | O: 1.59% H: 4.11% C: 0.78%
conference

---

Gainers vs Losers

59%

41%

Top 10 Gainers

WISA 4 | $6.06 246.29% 71.12% 200M |

Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K |

Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M |

Health Technology

SXTC | $1.68 43.59% 30.36% 34M |

Health Technology

DYNT | $0.531 43.36% 30.24% 22M |

Health Technology

KA | $0.4796 41.06% 29.11% 5.3M |

Manufacturing

PALI | $5.86 40.87% 29.01% 29M |

Manufacturing

CLNN | $0.319 -3.74% 28.75% 6.3M |

BSGM | $1.52 38.18% 27.63% 3.3M |

Health Technology

MCBC | $13.67 37.66% 27.36% 2.2M |

Finance

---

Your saved searches

---